Cargando…
Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells
BACKGROUND: Mesenchymal stem cells (MSCs) have been utilized in treating acute graft-versus-host disease (aGvHD) as they show strong immunosuppressive capacity through the release of various mediators, including immunosuppressive molecules, growth factors, chemokines, and exosomes. MicroRNAs (miRNAs...
Autores principales: | Liu, Weijiang, Zhou, Na, Liu, Yuanlin, Zhang, Wei, Li, Xue, Wang, Yang, Zheng, Rongxiu, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913292/ https://www.ncbi.nlm.nih.gov/pubmed/33637123 http://dx.doi.org/10.1186/s13287-021-02159-2 |
Ejemplares similares
-
Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis
por: Wei, Hong, et al.
Publicado: (2020) -
Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis
por: Wang, Xiaohong, et al.
Publicado: (2015) -
Correction: Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis
por: Wei, Hong, et al.
Publicado: (2020) -
Wip1 regulates the immunomodulatory effects of murine mesenchymal stem cells in type 1 diabetes mellitus via targeting IFN-α/BST2
por: Zhou, Na, et al.
Publicado: (2021) -
Human umbilical cord mesenchymal stem cell-derived TGFBI attenuates streptozotocin-induced type 1 diabetes mellitus by inhibiting T-cell proliferation
por: Wu, Chushan, et al.
Publicado: (2023)